153 related articles for article (PubMed ID: 8752252)
1. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Aderka D; Wallach D; Socol ML
Obstet Gynecol; 1996 Sep; 88(3):420-7. PubMed ID: 8752252
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Wigton TR; Rehnberg KA; Socol ML
Am J Obstet Gynecol; 1994 Jun; 170(6):1752-7; discussion 1757-9. PubMed ID: 8203436
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
Visser W; Beckmann I; Knook MA; Wallenburg HC
Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?
Greer IA; Lyall F; Perera T; Boswell F; Macara LM
Obstet Gynecol; 1994 Dec; 84(6):937-40. PubMed ID: 7526306
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptors for tumor necrosis factor: occurrence in association with normal delivery at term.
Austgulen R; Johnsen H; Kjøllesdal AM; Liabakk NB; Espevik T
Obstet Gynecol; 1993 Sep; 82(3):343-7. PubMed ID: 8395036
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Dollberg S; Socol ML
Am J Perinatol; 1999; 16(5):203-8. PubMed ID: 10535611
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nonspecific immunity and plasma levels of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in preeclampsia.
Munno I; Chiechi LM; Lacedra G; Berardesca C; Patimo C; Marcuccio L; Nardelli P; Loizzi P
Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):551-64. PubMed ID: 10466079
[TBL] [Abstract][Full Text] [Related]
10. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
11. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
12. Persistency of high proinflammatory cytokine levels from colostrum to mature milk in preeclampsia.
Erbağci AB; Cekmen MB; Balat O; Balat A; Aksoy F; Tarakçioğlu M
Clin Biochem; 2005 Aug; 38(8):712-6. PubMed ID: 15953598
[TBL] [Abstract][Full Text] [Related]
13. Feto-maternal bone remodeling in normal pregnancy and preeclampsia.
Shaarawy M; Zaki S; Ramzi AM; Salem ME; El-Minawi AM
J Soc Gynecol Investig; 2005 Jul; 12(5):343-8. PubMed ID: 15979546
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
[TBL] [Abstract][Full Text] [Related]
15. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.
Donker RB; Asgeirsdóttir SA; Gerbens F; van Pampus MG; Kallenberg CG; te Meerman GJ; Aarnoudse JG; Molema G
J Soc Gynecol Investig; 2005 Feb; 12(2):98-106. PubMed ID: 15695104
[TBL] [Abstract][Full Text] [Related]
16. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies.
Opsjøn SL; Novick D; Wathen NC; Cope AP; Wallach D; Aderka D
J Reprod Immunol; 1995 Jul; 29(2):119-34. PubMed ID: 7500319
[TBL] [Abstract][Full Text] [Related]
17. Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium.
Omu AE; Al-Qattan F; Diejomaoh ME; Al-Yatama M
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):675-80. PubMed ID: 10468058
[TBL] [Abstract][Full Text] [Related]
18. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
Enquobahrie DA; Williams MA; Qiu C; Woelk GB; Mahomed K
J Matern Fetal Neonatal Med; 2005 May; 17(5):343-8. PubMed ID: 16147848
[TBL] [Abstract][Full Text] [Related]
19. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
20. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
